A rare childhood uterine malignancy combined with complete uterine inversion

Česká verzia

Authors: Lucie Klenovská ¹ ; Ivana Meixnerová ¹ ; Luboš Minář ¹ ; Marta Ježová ²
Authors place of work: Gynekologicko-porodnická klinika LF MU a FN Brno ¹; Ústav patologie, LF MU a FN Brno ²
Published in the journal: Ceska Gynekol 2025; 90(3): 231-237
Category:
doi: https://doi.org/10.48095/cccg2025231

Summary

Objective: An overview of the types of uterine sarcoma, supplemented by an illustrative case report of a rare uterine childhood tumor. Case report: Our case report describes the case of a 9-year-old girl with a 15-cm tumor in the abdominal cavity, which prolapsed vaginally before introitus during a clinical examination of the abdominal wall causing life-threatening bleeding. This bleeding was stopped by ligation of the tumor pedicle and its resection. Histological examination of the resected specimen described Müllerian adenosarcoma of the uterus. Based on the staging, laparoscopic hysterectomy with bilateral salpingectomy was indicated by the oncogynecological committee. The operation was performed without complications, and intraoperatively, a complete inversion of the uterus was diagnosed.

Keywords:

Leiomyosarcoma – uterine inversion – uterine sarcoma – endometrial stromal sarcoma – Müllerian adenosarcoma

Zdroje

1. Mbatani M, Olawaiye AB, Prat J. Uterine sarcomas. Int J Gynecol Obstet 2018; 114 (Suppl 2): 51–58. doi: 10.1002/ijgo.12613.

2. Oliva E. Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations. Int J Gynecol Pathol 2014; 33 (4): 374–384. doi: 10.1097/PGP.0000000000000141.

3. Diagnosticko-léčebné protokoly MOÚ – gynekologické nádory. 2024 [online]. Dostupné z: https: //static.mou.cz/d/mou.cz/files/4373.pdf/s-baa20ffabc92?_ts=1715082385.

4. Špaček J, Laco J, Petera J et al. Prognostické faktory u mezenchymálních a smíšených nádorů děložního těla. Ceska Gynekol 2009; 74 (4): 292–297.

5. Giuntoli RL 2nd, Metzinger DS, DiMarco CS et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 2003; 89 (3): 460–469. doi: 10.1016/s0090-8258 (03) 00137-9.

6. Koivisto-Korander R, Butzow R, Koivisto AM et al. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001. Gynecol Oncol 2008; 111 (1): 74–81. doi: 10.1016/j.ygyno.2008.06.002.

7. Mayerhofer K, Obermair A, Windbichler G et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74 (2): 196–201. doi: 10.1006/gyno.1999.5436.

8. Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 2008; 112 (4): 820–830. doi: 10.1002/cncr. 23245.

9. D‘Angelo E, Espinosa I, Ali R et al. Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis. Gynecol Oncol 2011; 121 (2): 328–333. doi: 10.1016/j.ygyno.2011. 01.022.

10. Chan JK, Kawar NM, Shin JY et al. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 2008; 99 (8): 1210-1215. doi: 10.1038/sj.bjc.6604527.

11. Lee CH, Mariño-Enriquez A, Ou W et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol 2012; 36 (5): 641–653. doi: 10.1097/PAS.0b013e31824a7b1a.

12. Tanner EJ, Garg K, Leitao MM Jr et al. High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol Oncol 2012; 127 (1): 27–31. doi: 10.1016/ j.ygyno.2012.06.030.

13. Li JY, Mutlu L, Tymon-Rosario J et al. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecol Oncol Rep 2021; 39: 100913. doi: 10.1016/j.gore.2021.100913.

14. Ghartimagar D, Shrestha B, Ghosh A et al. Adenosarcoma of uterus – rare biphasic malignant tumor: a case report. JNMA J Nepal Med Assoc 2021; 59 (234): 200–203. doi: 10.31729/ jnma.5373.

15.Wang Q, Sun S, Cai J et al. Uterine adenosarcoma: a case report and review of the literature. Am J Nucl Med Mol Imaging 2023; 13 (2): 70–76.

16. Hasegawa C, Washimi K, Hiroshima Y et al. Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling. Diagn Pathol 2023; 18 (1): 5. doi: 10.1186/s13000-022-01279-4.

17. Doporučené postupy ČGPS ČLS JEP – Sledování pacientek po léčbě prekanceróz a zhoubných nádorů ženských pohlavních orgánů. 2019 [online]. Dostupné z: https: //cgps.cz/doporucene-postupy/onkogynekologie/ o-2019-07-sledovani-pacientek-po-lecbe-prekanceroz-a-zn-zenskych-pohlavnich-organu/ ?layout=default.

18. Hořínová V, Drábová K, Nosková H e tal. Syndrom DICER1. Klin Onkol 2019; 32 (Suppl 2): 123–127. doi: 10.14735/amko2019S123.

19. Dušek L, Mužík J, Kubásek M et al. Epidemiologie zhoubných nádorů v České republice. 2024 [online]. Dostupné z: https: //www.svod.cz/.

20. Zizolfi B, Foreste V, Di Spiezio Sardo A et al. Fertility sparing management of uterine adenosarcoma: case report and literature review. Facts Views Vis Obgyn 2021; 12 (4): 315–318.

21. Goh C, Lin XH, Chin PS et al. Uterine preservation in a young patient with adenosarcoma of the uterus – case report and review of literature. Gynecol Oncol Rep 2018; 25: 27–29. doi: 10.1016/j.gore.2018.05.002.

22. Wang Q, Sun S, Cai J et al, Uterine adenosarcoma: a case report and review of the literature. Am J Nucl Med Mol Imaging 2023; 13 (2): 70–76.

23. de Vries M, Perquin DA. Non-puerperal uterine inversion due to submucous myoma in a young woman: a case report. J Med Case Rep 2010; 4: 21. doi: 10.1186/1752-1947-4-21.

24. Mužná L, Pilka R. Inverze dělohy. Ceska Gynekol 2017; 82 (2): 139–144.

25. Leconte I, Cecile T, Bongiorno A et al. Non--puerperal uterine inversion. J Belg Soc Radiol 2016; 100 (1): 47. doi: 10.5334/jbr-btr.974.

ORCID autorů

L. Klenovská 0009-0003-2297-9627

I. Meixnerová 0000-0002-4837-4795

L. Minář 0000-0001-9088-5428

Doručeno/Submitted: 4. 12. 2024

Přijato/Accepted: 12. 12. 2024

doc. MUDr. Luboš Minář, Ph.D.

Gynekologicko-porodnická klinika

LF MU a FN Brno

Obilní trh 526/11